Abstract
Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in Men with High-Risk Biochemically Recurrent Prostate Cancer and Prior Radiotherapy: EMBARK Subgroup Analysis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have